Evidence map›Paper›PMID 28632185›Full record

ArticleMolecules (Basel, Switzerland)2017

The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines.

Martin Ambrož, Petra Matoušková, Adam Skarka, Martina Zajdlová, Kateřina Žáková, Lenka Skálová

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. The Wild Carrot (Plants (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Mechanism ofCancers · 2023
    Article
  6. Article
  7. Combination of Chemically-Characterized Essential Oils fromAdvances in pharmacological and pharmaceutical sciences · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Martin AmbrožDepartment of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. ambrozm@faf.cuni.cz.
Petra MatouškováDepartment of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. matousp7@faf.cuni.cz.
Adam SkarkaDepartment of Chemistry, Faculty of Science, University of Hradec Králové, Hradecká 1285, 50003 Hradec Králové, Czech Republic. adam.skarka@uhk.cz.
Martina ZajdlováDepartment of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. m.zajdlova@gmail.com.
Kateřina ŽákováDepartment of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Katerina.zakova@gmail.com.
Lenka SkálováDepartment of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. lenka.skalova@faf.cuni.cz.
Charles University · CZUniversity of Hradec Králové · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-caryophyllene oxide (CAO), α-humulene (HUM), trans-nerolidol (NER) and valencene (VAL) are constituents of the essential oil of

Indexed as

Cell Line, TumorCell ProliferationCell SurvivalDoxorubicinDrug Resistance, MultipleDrug SynergismDrug Therapy, CombinationHumansMonocyclic SesquiterpenesMyricaOils, VolatilePolycyclic SesquiterpenesPrecursor Cell Lymphoblastic Leukemia-LymphomaSesquiterpenescaryophyllene oxideDoxorubicinhumuleneMonocyclic SesquiterpenesnerolidolOils, VolatilePolycyclic SesquiterpenesSesquiterpenesvalenceneABCB1 transporterAdriamycindrug combinationsdrug resistanceterpenes

Identifiers

PMID28632185
PMCPMC6152637
OpenAlexW2720104353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.